fr   en

Tableaux synoptiques (en anglais)

Parcourir par date
Rechercher par mot clé
Date: 2010-08-23
Acquiring pharma company: Roche (Switzerland)
Acquired biotech company: BioImagene (USA)
Amount: $100 million
Terms of the agreement: Roche has signed an agreement under which Ventana Medical Systems, a member of the Roche Group, will acquire 100 percent of the US company BioImagene. BioImagene is a provider of innovative and scalable digital pathology solutions. The company's total digital pathology solution is comprised of the Virtuoso™ digital pathology application software, iScan™ family of automated digital slide scanners, and a rich menu of Companion Algorithms™.
BioImagene brings to Ventana additional capabilities for scanning and analysing tissue that are not possible in the glass-slide world. This acquisition is part of Roche’s personalised healthcare approach